"Siemens" fructosamine reagent group
Taiwan·Risk Class 2·RANDOX LABORATORIES LIMITED;; SIEMENS HEALTHCARE DIAGNOSTICS INC.·Registered Mar 13, 2014 – Mar 13, 2029Active- Analysis ID
- 61f3c9c0942cd59ed7f5295ff38189b8
- Customs Code
- DHA05602591602
- Manufacturer Country
- United Kingdom;;United States
- Authorized Representative
- SIEMENS HEALTHCARE LIMITED
- Intended Use
- This product is used in conjunction with the ADVIA chemical system (ADVIA 1200, 1650/1800 and 2400) to quantify the concentration of glycosylated protein (fructosamine) in human serum or plasma for in vitro diagnostic use only.
- Product Type (Level 1)
- B Haematology, pathology and genetics; A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1150 calibration;; B.7470 Analysis of glycosylated hemoglobin
- Import Information
- Input;; Contract manufacturing
- Registration Date
- Mar 13, 2014
- Expiry Date
- Mar 13, 2029
Top companies providing products similar to ""Siemens" fructosamine reagent group"
Recently registered similar products
Access comprehensive regulatory information for "Siemens" fructosamine reagent group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 61f3c9c0942cd59ed7f5295ff38189b8 and manufactured by RANDOX LABORATORIES LIMITED;; SIEMENS HEALTHCARE DIAGNOSTICS INC.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including RANDOX LABORATORIES LTD.;; Siemens Healthcare Diagnostics Inc., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.